Financial statements G-Pharma Consulting
Balance sheet of G-Pharma Consulting
Company age:
Age:
9 y. 6 m. 3 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of G-PHARMA CONSULTING
|
Year
|
2020
|
2021
|
|---|---|---|
| Total assets | 4 198 985,16 | 3 716 448,29 |
| A. Fixed assets | 3 559 590,00 | 3 187 485,52 |
| B. Current assets | 119 395,16 | 8 962,77 |
| C. Share capital contributions (basic funds) | 520 000,00 | 520 000,00 |
| D. Own shares (stocks) | - | - |
| Total liabilities | 4 198 985,16 | 3 716 448,29 |
| A. Equity | 981 756,17 | 780 938,36 |
| B. Liabilities and provisions for liabilities | 3 217 228,99 | 2 935 509,93 |
| I. Long-term liabilities | 0,00 | 0,00 |
| II. Short-term liabilities | 3 217 228,99 | 2 935 509,93 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.